Abstract:Introduction: Primary breast lymphoma (PBL) is rare, and most cases occur in female patients, with few reported cases in male patients. The clinical presentation is similar to that of breast cancer, but the condition needs to be well understood, as treatment options and clinical course vary. Hence, we provide a relatively rare case of primary breast diffuse large B cell lymphoma (PB-DLBCL) in a male, including its complete clinicopathological features, radiological findings, genomic mutational profiles, and clinical course. Case presentation: A 45-year-old male presented with a lump in his right breast for 1 week and was pathologically diagnosed with breast malignancy after a breast puncture biopsy at the local hospital. He came to our hospital for further treatment and underwent breast ultrasound and systemic positron emission tomography/computed tomography (PET/CT) imaging, followed by right mastectomy and sentinel lymph node biopsy. Histomorphology showed diffuse hyperplasia of tumor cells with clear boundaries and surrounding normal breast ducts. The adhesion of tumor cells was poor with obvious atypia. Immunohistochemical results showed that the tumor cells were positive for CD20, Bcl6, and MUM-1 but negative for CK (AE1/AE3), ER, PR, CD3, and CD10. Forty percent of the tumor cells were positive for c-Myc, and 80% of tumor cells were positive for Bcl2. The Ki-67 proliferation index was up to 80%. The tumor cells were negative for MYC and BCL2 rearrangements but positive for BCL6 rearrangement by fluorescent in situ hybridization. No abnormality was found in the pathological examination of bone marrow aspiration. Therefore, the male was diagnosed with PB-DLBCL, nongerminal center (non-GCB) phenotype, dual-expression type. The sample were sequenced by a target panel of 121 genes related to lymphoma. Next-generation sequencing revealed six tumor-specific mutated genes (IGH/BCL6, TNFAIP3, PRDM1, CREBBP, DTX1, and FOXO1). The patient was given six cycles of orelabrutinib plus R-CHOP chemotherapy and two cycles of intrathecal injection of cytarabine. The last follow-up was on April 13, 2023 (17 months). No recurrence or metastasis was found in laboratory and imaging examinations. Conclusion: We reported a relatively rare PB-DLBCL in a male, non-GBC phenotype, dual-expression type. It is worth mentioning that this case had IgH/BCL6 fusion, nonsense mutations in TNFAIP3, frameshift mutations in PRDM1, and missense mutations in CREBBP, DTX1, and FOXO1. To the best of our knowledge, this case is the first report of genomic mutational profiles of PB-DLBCL in males.

Infiltrating Ductal Breast Carcinoma in a Male Patient With Associated BARD1 Mutation

Clinicopathological Characteristics and Outcomes of Male Patients with Resected Distant Metastasis-Free Breast Cancer in A Single Center

Magnetic resonance imaging findings of high-grade ductal carcinoma in situ of the male breast: A case report

Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy

Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review

A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast

Melanocytic Malignant Peripheral Nerve Sheath Tumor of the Male Breast

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

Intraductal Carcinoma and Carcinosarcoma with Bone Metastases Presenting in One Breast: A Case Report.

Male Breast Cancer and Mantle Cell Lymphoma in a Single Patient A Case Report and Literature Review

Cystic encapsulated papillary carcinoma with ductal carcinoma in situ in the male breast: a clinicopathologic feature with a diagnostic challenge: A case report and review of literature

Primary mucinous cystadenocarcinoma of the breast: A case report and literature review

Male axillary accessory breast cancer: A case report

Male breast cancer metastasising to the liver: A case report

Male Breast Imaging Uncovers Lymphoma

Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient

A case report of a patient with ductal carcinoma and a malignant phyllodes tumor in situ in 2 separate breasts

Non-Hodgkin's Lymphoma Within a Breast Abscess in a Male Patient: A Presentation and Literature Review of a Rare Case

Solid Papillary Carcinoma with Invasion in the Male Breast: A Case Report and Literature Review

Mammary myofibroblastoma of the male breast: a case report and literature review

BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case